Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
KYinno
Dongcheng District, China
D
11-50 Employees
2017
Key takeaway
The company offers a specialized service for developing genetically engineered cell lines, including those for studying kinase-related processes and immune system functions. Their Gene Editing Cell Line service utilizes advanced techniques to create customizable cell lines for precise research into genetic mechanisms and therapeutic development.
Reference
Product
Reporter Cell Line_Stable Cell Line Products_KYinno
Viva Biotech (Shanghai) Ltd.
Huangpu District, China
D
1001-5000 Employees
-
Key takeaway
Viva Biotech specializes in Structure-Based Drug R&D, offering comprehensive services that include early-stage drug discovery and commercial manufacturing. Their experienced team and advanced technology platforms support innovative drug development, which may involve the creation and optimization of cell lines for research purposes.
Reference
Product
Cell-Lines
Biocytogen
Daxing District, China
D
1001-5000 Employees
2008
Key takeaway
Biocytogen specializes in the development of fully human monoclonal antibodies and offers custom cell line generation to meet specific research needs. Their integrated solutions and genetically modified BioMice support advanced preclinical research and antibody drug development.
Reference
Product
Other Cancer Cell Lines Archives - Biocytogen
Don’t see the line you’re looking for? Our team can generate custom cell lines for your specific needs. Request a Custom Cell Line Here!
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
WuXi Biologics
Xuancheng, China
D
5001-10000 Employees
2014
Key takeaway
WuXi Biologics offers comprehensive mammalian cell line development (CLD) capabilities, starting from client-provided DNA or protein sequences to the delivery of high-yielding, well-characterized, stable single clones. Their dedicated CLD platform, named "WuXia," emphasizes quality and stability, making it a valuable resource for developing biotherapeutics.
Reference
Product
WuXia
WuXi Biologics offers comprehensive mammalian cell line development (CLD) capabilities for various biotherapeutics. Our program typically starts with client-provided DNA or protein sequences and ends with the delivery of high-yielding, well-characterized, stable single clones. The Chinese word “WuXia” translates to “flawless or ideal” in English. Hence, this is why we chose to name our cell line development (CLD) platform “WuXia.”
Quacell Biotechnology
Jiangmen, China
D
101-250 Employees
2018
Key takeaway
Kangsheng Biotechnology specializes in cell line and culture medium development, offering a one-stop solution from R&D to production. They produce industrial-grade, serum-free culture media formulations in accordance with GMP standards, featuring key products like CHO-K1Q and HEK 293 cell lines.
Reference
Core business
康晟生物—细胞株及培养基专业生产者
BrainVTA
Wuhan, China
D
51-100 Employees
2014
Key takeaway
BrainVTA specializes in stable cell line generation, offering high-quality and high-titer viral preparation services that are essential for scientific research. Their expertise in developing cell lines and viral preparations supports advancements in the life sciences.
Reference
Service
Stable Cell Line Generation| BrainVTA
Sanyou Bio
Huangpu District, China
D
101-250 Employees
2015
Key takeaway
Sanyou Biopharmaceuticals Co., Ltd. specializes in the development of innovative biological drugs, with a strong focus on research and development. They have established a comprehensive platform that includes expertise in production cell line construction, which is crucial for effective cell line development.
Reference
Product
Research Overexpression Cell Line Construction-Sanyou Biopharmaceuticals Co., Ltd.
OncoGenerix
China
D
251-500 Employees
2009
Key takeaway
OncoGenerix specializes in injectable process development and manufacturing, offering a comprehensive range of contract manufacturing services that emphasize quality and compliance with regulatory standards.
Reference
Service
OncoGenerix - Services
Beijing Origene Biotechnology Co., Ltd.
Dongcheng District, China
D
11-50 Employees
2006
Key takeaway
OriGene specializes in genome-wide lentiviral and AAV vectors, providing custom AAV packaging and lentiviral particle packaging kits that optimize the delivery of genetic material into both dividing and non-dividing cells. Their lentiviral products have demonstrated consistent efficacy in gene knockdown, enabling researchers to effectively assess the impact of gene absence during early cell engraftment stages.
Reference
Service
Assay Development | OriGene
WuXi AppTec
Huangpu District, China
D
10001+ Employees
2000
Key takeaway
WuXi AppTec offers integrated CRDMO services that support the development of cell and gene therapies, providing a comprehensive solution to accelerate the time to market for these innovations. The company's recent FDA approval for manufacturing a novel therapy for advanced melanoma further highlights its capabilities in this area.
Reference
Service
Cell Therapy and Gene Therapy | WuXi AppTec
Technologies which have been searched by others and may be interesting for you:
When exploring the Cell Line Development industry in China, several key considerations come into play. Firstly, understanding the regulatory landscape is crucial, as China has specific guidelines governing biopharmaceutical development, including approvals from the National Medical Products Administration (NMPA). Compliance with these regulations is essential for successful operations. Additionally, the competitive landscape in China is rapidly evolving, with both domestic and international players vying for market share. This presents both opportunities and challenges. Companies seeking partnerships should consider the reputation and experience of local firms in navigating the unique market dynamics. Moreover, environmental concerns are increasingly relevant, particularly regarding waste management and sustainability practices in biomanufacturing. Organizations must prioritize eco-friendly processes to align with global sustainability trends. The global market relevance of China's Cell Line Development industry cannot be overlooked, as the country is becoming a hub for biopharmaceutical innovation and production. Collaborating with local entities can provide access to advanced technologies and expertise, enhancing competitiveness in the global arena. Overall, a comprehensive understanding of regulations, market dynamics, environmental considerations, and collaboration opportunities is vital for anyone interested in the Cell Line Development sector in China.
Some interesting numbers and facts about your company results for Cell Line Development
| Country with most fitting companies | China |
| Amount of fitting manufacturers | 185 |
| Amount of suitable service providers | 111 |
| Average amount of employees | 251-500 |
| Oldest suiting company | 2000 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for Cell Line Development
What are related technologies to Cell Line Development?
Based on our calculations related technologies to Cell Line Development are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Cell Line Development?
The most represented industries which are working in Cell Line Development are Biotechnology, Other, Medical, Pharmaceuticals, Chemicals
How does ensun find these Cell Line Development Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.